The Future of Heart Failure Therapy
Anuradha Lala-Trindade, MD, shares developments in the pipeline for heart failure therapy, as well as clinical pearls for health care providers managing patients with heart failure.
Read More
Clinical Trials of Sacubitril/Valsartan in Heart Failure
Anuradha Lala-Trindade, MD, discusses the PARAGLIDE-HF trials, highlighting the use of sacubitril/valsartan for the management of heart failure in certain populations.
Unmet Needs in the Management of Heart Failure
An expert cardiologist comments on unmet needs in the management of heart failure, highlighting the need to categorize patients with heart failure in order to better treat them.
Personalizing Quadruple Therapy in Heart Failure
Anuradha Lala-Trindade, MD, shares approaches to personalizing quadruple therapy for people with heart failure, focusing on family history, device-based therapies, and optimizing therapy early.
Use of SGLT-2 Inhibitors in Heart Failure
Anuradha Lala-Trindade, MD, provides an overview of SGLT2 inhibitors for the management of heart failure, as well as their clinical trial data.
Quadruple Therapy for Patients With Heart Failure
An expert cardiologist reviews the foundational pillars of quadruple-based, guideline therapies for heart failure, as well as the contraindications for these drugs.
Prevalence and Risk Factors of Heart Failure
Anuradha Lala-Trindade, MD, comments on the prevalence of the various types of heart failure, as well as risk factors leading to the disorder.
Challenges in Heart Failure Management
Anuradha Lala-Trindade, MD, discusses the challenges in managing heart failure in the United States as well as the universal definition of heart failure and classification by left ventricle ejection fraction (EF).